The use of bioprosthetic prostheses during surgical aortic valve replacements has increased
dramatically over the last two decades, accounting for over 85% of surgical implantations …

Transcatheter aortic valve replacement (TAVR) has proven to be a safe, effective, and less
invasive approach to aortic valve replacement in patients with aortic stenosis. In patients …

Background Bioprosthetic valve fracture (BVF) can be used to improve transcatheter heart
valve (THV) haemodynamics following a valve-in-valve (ViV) intervention. However, whether …

Background: Sutureless aortic bioprostheses are increasingly being used to provide shorter
cross-clamp time and facilitate minimally invasive aortic valve replacement. As the use of …

Background Favourable early outcomes have been reported following valve-in-valve
transcatheter mitral valve replacement (TMVR). However, reports of long-term outcomes are …

A 61-year-old male who underwent aortic valve replacement with an Inspiris Resilia® aortic
bioprosthetic through an upper partial sternotomy due to severe aortic valve stenosis was …

Background There are limited data on the effect of bioprosthetic valve remodeling (BVR) on
transcatheter heart valve (THV) expansion and function following valve-in-valve (VIV) …

The INSPIRIS RESILIA valve is designed to dilate its valve annulus in transcatheter aortic
valve-in-surgical aortic valve (TAV-in-SAV), a catheter therapy for biological valve …

Over the last decades, bioprosthetic heart valves (BHV) have been increasingly implanted
instead of mechanical valves in patients undergoing surgical aortic valve replacement …

Transcatheter aortic valve-in-valve replacement presents a viable, minimally invasive
approach to replacing degraded bioprosthetic surgical valves. The major drawback of this …